The increasing field of immunotherapy relies heavily on recombinant growth factor technology, and a precise understanding of individual profiles is absolutely crucial for fine-tuning experimental design and therapeutic efficacy. Specifically, examining the properties of recombinant IL-1A, IL-1B, IL-2, and IL-3 demonstrates important differences in